JP Morgan Chase’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Buy
+30,000
New +$2.99M ﹤0.01% 3870
2025
Q2
Sell
-64,600
Closed -$3.91M 7364
2025
Q1
$3.91M Buy
+64,600
New +$4.5M ﹤0.01% 3370
2022
Q1
Sell
-57,500
Closed -$4.22M 6794
2021
Q4
$4.22M Buy
+57,500
New +$3.88M ﹤0.01% 3208
2021
Q2
Sell
-11,800
Closed -$959K 6457
2021
Q1
$959K Buy
+11,800
New +$1.01M ﹤0.01% 4265
2019
Q1
Sell
-600
Closed -$38K 5900
2018
Q4
$38K Hold
600
﹤0.01% 5170
2018
Q3
$41K Buy
+600
New +$41.2K ﹤0.01% 5265
2018
Q2
Sell
-146,000
Closed -$12.2M 5603
2018
Q1
$12.2M Buy
146,000
+136,600
+1,453% +$12.3M ﹤0.01% 1881
2017
Q4
$890K Sell
9,400
-235,000
-96% -$24.6M ﹤0.01% 3788
2017
Q3
$27.7M Buy
+244,400
New +$30.9M 0.01% 1276

Other funds holding INCY

JP Morgan Chase's INCY Position: Q1 2026 in Review

JP Morgan Chase increased its Incyte (INCY) stake by 12% in Q1 2026, buying an estimated $5.35M and bringing the position to 497,042 shares worth $44.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

JP Morgan Chase first reported a position in INCY in Q2 2013 and has held it in 52 quarters since. The position peaked at $428M in Q4 2015. 811 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • JP Morgan Chase held 497,042 shares of Incyte worth $44.9M as of Q1 2026.
  • JP Morgan Chase bought 53,606 Incyte shares in Q1 2026, an estimated $5.35M.
  • Incyte made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1460 holding.
  • JP Morgan Chase first reported a position in Incyte in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Incyte position peaked at $428M in Q4 2015.
  • 811 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.